Conference Reports for NaTaP

EASL - The International Liver Congress 2015 50th annual Meeting of the European association for the Study of the Liver Vienna, austria  april 22-26 Back

PHARMACOKINETICS OF PARITAPREVIR, OMBITASVIR, DASABUVIR, RITONAVIR AND RIBAVIRIN IN SUBJECTS WITH HCV GENOTYPE 1 INFECTION IN PHASE 3 STUDIES       EASL: Abbvie at EASL 2015 - Healthcare Economics, Clinical Trials - (05/11/15)   Reported by Jules Levin EASL 2015 April 22-26 Vienna Austria   Sven Mensing Germany et al